Prostaglandin E2 EP Receptors in Cardiovascular Disease: An Update.
Sign Up to like & getrecommendations! Published in 2021 at "Biochemical pharmacology"
DOI: 10.1016/j.bcp.2021.114858
Abstract: This review article provides an update for the role of prostaglandin E2 receptors (EP1, EP2, EP3 and EP4) in cardiovascular disease. Where possible we have reported citations from the last decade although this was not… read more here.
Keywords: cardiovascular disease; receptors cardiovascular; disease update; prostaglandin receptors ... See more keywords
Agonists of prostaglandin E2 receptors as potential first in class treatment for nephronophthisis and related ciliopathies
Sign Up to like & getrecommendations! Published in 2022 at "Proceedings of the National Academy of Sciences of the United States of America"
DOI: 10.1073/pnas.2115960119
Abstract: Significance Juvenile nephronophthisis (NPH) is a renal ciliopathy due to a dysfunction of primary cilia for which no curative treatment is available. This paper describes the identification of agonists of prostaglandin E2 receptors as a… read more here.
Keywords: receptors potential; prostaglandin receptors; potential first; agonists prostaglandin ... See more keywords